Pace Gary W
- SEC CIK
- 0001184778
In the past year, 2 open-market purchase filings worth $1.04M and no sales.
Current role at each company
- CRDF Cardiff Oncology, Inc.Directoras of Jul 16, 2026
- PCRX Pacira BioSciences, Inc.Directoras of Mar 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.04M
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$1.04M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pace Gary W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRDF Cardiff Oncology, Inc.
Director11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 (view filing) | Sep 21 | 1 day | Pace Gary WDirector | PPurchase | +30.0K | $6.75 | +$202.5K | +6.5%494.8K after | |
| Sep 19, 2022 (view filing) | Sep 15 | 4 days | Pace Gary WDirector | PPurchase | +150.0K | $1.71 | +$256.5K | +30.3%644.8K after | |
| Nov 14, 2023 (view filing) | Nov 10 | 4 days | Pace Gary WDirector | PPurchase | +22.9K | $0.98 | +$22.5K | +3.6%667.8K after | |
| Dec 19, 2023 (view filing) | Dec 19 | Same day | Pace Gary WDirector | PPurchase | +30.0K | $1.37 | +$41.1K | +4.5%697.8K after | |
| Dec 12, 2024 (view filing) | Dec 11 | 1 day | Pace Gary WDirector | PPurchase | +350.1K | $2.60 | +$910.3K | +50.2%1.05M after | |
| Dec 12, 2024 (view filing) | Dec 11 | 1 day | Pace Gary WDirector | PPurchase | +11.5K | $2.60 | +$29.9K | +1.1%1.06M after | |
| Jul 31, 2025 (view filing) | Jul 30 | 1 day | Pace Gary WDirector | PPurchase | +275.0K | $2.45 | +$673.8K | +26.0%1.33M after | |
| Jul 31, 2025 (view filing) | Jul 30 | 1 day | Pace Gary WDirector | PPurchase | +15.0K | $2.45 | +$36.8K | +1.1%1.35M after | |
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Pace Gary WDirector | PPurchase | +30.0K | $1.22 | +$36.6K | +2.3%1.36M after | |
| Jul 16, 2026 (view filing)4:03 PM ET | Jul 14 | 2 days | Pace Gary WDirector | PPurchase | +687.3K | $1.46 | +$1.00M | +50.7%2.04M after |
PCRX Pacira BioSciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 (view filing) | Feb 28-Mar 1 | 1 day | Pace Gary WDirector | SSale | −30.0K | $66.87 | −$2.01M | −18.8%129.5K after | 2 lots |
| May 15, 2023 (view filing) | May 11 | 4 days | Pace Gary WDirector | SSale | −5.01K | $41.78 | −$209.5K | −3.5%139.7K after | |
| Mar 8, 2024 (view filing) | Mar 6-8 | 2 days | Pace Gary WDirector | SSale | −119.3K | $30.64 | −$3.66M | −84.4%22.1K after | 3 lots |